Cooperative, Nanoparticle-Enabled Thermal Therapy of Breast Cancer

被引:77
作者
Shen, Haifa [1 ]
You, Jian [2 ]
Zhang, Guodong [1 ]
Ziemys, Arturas [1 ]
Li, Qingpo [1 ]
Bai, Litao [1 ]
Deng, Xiaoyong [1 ]
Erm, Donald R. [1 ]
Liu, Xuewu [1 ]
Li, Chun [2 ]
Ferrari, Mauro [1 ]
机构
[1] Methodist Hosp, Res Inst, Dept Nanomed, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA
关键词
GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; ALBUMIN-BOUND PACLITAXEL; ACQUIRED-RESISTANCE; SURFACE-PLASMON; T790M MUTATIONS; GOLD; GEFITINIB; ABLATION; DELIVERY;
D O I
10.1002/adhm.201100005
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
[No abstract available]
引用
收藏
页码:84 / 89
页数:6
相关论文
共 45 条
[1]  
Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]
[2]   Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor - Mutant lung adenocarcinomas with acquired resistance to kinase inhibitors [J].
Balak, Marissa N. ;
Gong, Yixuan ;
Riely, Gregory J. ;
Somwar, Romel ;
Li, Allan R. ;
Zakowski, Maureen F. ;
Chiang, Anne ;
Yang, Guangli ;
Ouerfelli, Ouathek ;
Kris, Mark G. ;
Ladanyi, Marc ;
Miller, Vincent A. ;
Pao, William .
CLINICAL CANCER RESEARCH, 2006, 12 (21) :6494-6501
[3]   MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib [J].
Bean, James ;
Brennan, Cameron ;
Shih, Jin-Yuan ;
Riely, Gregory ;
Viale, Agnes ;
Wang, Lu ;
Chitale, Dhananjay ;
Motoi, Noriko ;
Szoke, Janos ;
Broderick, Stephen ;
Balak, Marissa ;
Chang, Wen-Cheng ;
Yu, Chong-Jen ;
Gazdar, Adi ;
Pass, Harvey ;
Rusch, Valerie ;
Gerald, William ;
Huang, Shiu-Feng ;
Yang, Pan-Chyr ;
Miller, Vincent ;
Ladany, Marc ;
Yang, Chih-Hsin ;
Pao, William .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20932-20937
[4]   Size and shape effects in the biodistribution of intravascularly injected particles [J].
Decuzzi, P. ;
Godin, B. ;
Tanaka, T. ;
Lee, S. -Y. ;
Chiappini, C. ;
Liu, X. ;
Ferrari, M. .
JOURNAL OF CONTROLLED RELEASE, 2010, 141 (03) :320-327
[5]   Design maps for nanoparticles targeting the diseased microvasculature [J].
Decuzzi, Paolo ;
Ferrari, Mauro .
BIOMATERIALS, 2008, 29 (03) :377-384
[6]   Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice [J].
Dickerson, Erin B. ;
Dreaden, Erik C. ;
Huang, Xiaohua ;
El-Sayed, Ivan H. ;
Chu, Hunghao ;
Pushpanketh, Sujatha ;
McDonald, John F. ;
El-Sayed, Mostafa A. .
CANCER LETTERS, 2008, 269 (01) :57-66
[7]   Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib [J].
Eberhard, DA ;
Johnson, BE ;
Amler, LC ;
Goddard, AD ;
Heldens, SL ;
Herbst, RS ;
Ince, WL ;
Jänne, PA ;
Januario, T ;
Johnson, DH ;
Klein, P ;
Miller, VA ;
Ostland, MA ;
Ramies, DA ;
Sebisanovic, D ;
Stinson, JA ;
Zhang, YR ;
Seshagiri, S ;
Hillan, KJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5900-5909
[8]   MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling [J].
Engelman, Jeffrey A. ;
Zejnullahu, Kreshnik ;
Mitsudomi, Tetsuya ;
Song, Youngchul ;
Hyland, Courtney ;
Park, Joon Oh ;
Lindeman, Neal ;
Gale, Christopher-Michael ;
Zhao, Xiaojun ;
Christensen, James ;
Kosaka, Takayuki ;
Holmes, Alison J. ;
Rogers, Andrew M. ;
Cappuzzo, Federico ;
Mok, Tony ;
Lee, Charles ;
Johnson, Bruce E. ;
Cantley, Lewis C. ;
Janne, Pasi A. .
SCIENCE, 2007, 316 (5827) :1039-1043
[9]   Cancer nanotechnology: Opportunities and challenges [J].
Ferrari, M .
NATURE REVIEWS CANCER, 2005, 5 (03) :161-171
[10]   EXPERIMENTAL THERAPIES Vectoring siRNA therapeutics into the clinic [J].
Ferrari, Mauro .
NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (09) :485-486